Telix Pharma, Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer Post author:Sam Post published:January 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017 Alexion is Under Investigation by the Office of Inspector General July 6, 2017 $710M Gamble Fails as Celgene Terminates Two Phase III Trials October 19, 2017
Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017